What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?

by Anil Pooran, Elize Pieterson, Malika Davids, Grant Theron, Keertan Dheda
Published 2013-01-01

Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa.

by Karen Shean, Elizabeth Streicher, Elize Pieterson, Greg Symons, Richard van Zyl Smit, Grant Theron, Rannakoe Lehloenya, Xavier Padanilam, Paul Wilcox, Tommie C Victor, Paul van Helden, Martin P Grobusch, Robin Warren, Motasim Badri, Keertan Dheda
Published 2013-01-01

Correction: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa

by Karen Shean, Elizabeth Streicher, Elize Pieterson, Greg Symons, Richard van Zyl Smit, Grant Theron, Rannakoe Lehloenya, Xavier Padanilam, Paul Wilcox, Tommie C. Victor, Paul van Helden, Martin P. Grobusch, Robin Warren, Motasim Badri, Keertan Dheda
Published 2013-01-01

Correction: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa.

by Karen Shean, Elizabeth Streicher, Elize Pieterson, Greg Symons, Richard van Zyl Smit, Grant Theron, Rannakoe Lehloenya, Xavier Padanilam, Paul Wilcox, Tommie C. Victor, Paul van Helden, Martin P. Grobusch, Robin Warren, Motasim Badri, Keertan Dheda
Published 2013-01-01